Alpha-fetoprotein in maternal serum and/or amniotic fluid is increased in all except
**Core Concept**
Alpha-fetoprotein (AFP) is a major plasma protein produced by the yolk sac and fetal liver during pregnancy. It serves as a marker for fetal development and is often used in prenatal screening to detect potential fetal abnormalities.
**Why the Correct Answer is Right**
In maternal serum and/or amniotic fluid, an increased level of AFP is a significant indicator of certain fetal anomalies and maternal conditions. The primary conditions associated with elevated AFP levels include:
* **Open neural tube defects (ONTDs)**: Spina bifida and anencephaly, where the neural tube fails to close properly, leading to the release of AFP into the amniotic fluid and maternal circulation.
* **Multiple gestations**: Carrying twins, triplets, or other multiple fetuses increases the overall AFP levels due to the higher number of fetuses producing AFP.
* **Chromosomal abnormalities**: Certain chromosomal conditions, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), are associated with elevated AFP levels.
* **Fetal abdominal wall defects**: Omphalocele and gastroschisis, where the abdominal contents protrude through the navel or abdominal wall, respectively, leading to the release of AFP into the amniotic fluid.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because AFP is not typically associated with **multiple sclerosis**, a chronic autoimmune disease affecting the central nervous system. While AFP may be elevated in certain neurological conditions, it is not a marker for multiple sclerosis.
**Option B:** Incorrect because AFP is not typically associated with **gestational diabetes mellitus (GDM)**. While GDM can have various complications, elevated AFP levels are not a direct consequence of this condition.
**Option C:** Incorrect because AFP is not typically associated with **fetal cardiac defects**. While certain cardiac anomalies may be detected through prenatal screening, elevated AFP levels are not a specific indicator for cardiac defects.
**Option D:** Incorrect because AFP is not typically associated with **maternal obesity**. While obesity can increase the risk of various pregnancy complications, elevated AFP levels are not a direct consequence of maternal obesity.
**Clinical Pearl / High-Yield Fact**
It is essential to remember that AFP levels should be interpreted in conjunction with other prenatal screening markers, such as beta-hCG and estriol, to provide a comprehensive assessment of fetal health.
**Correct Answer: C. Fetal cardiac defects.**